tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yatin Suneja, 152 are a BUY (84.44%), 28 are a HOLD (15.56%).
Analyst Yatin Suneja, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 37.97% that have a potential upside of 31.31% achieved within 177 days.
Yatin Suneja’s has documented 421 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TRML, Tourmaline Bio at 14-Aug-2025.
Analyst best performing recommendations are on IMVT (IMMUNOVANT ).
The best stock recommendation documented was for IMVT (IMMUNOVANT ) at 9/22/2023. The price target of $32 was fulfilled within 4 days with a profit of $11.61 (56.94%) receiving and performance score of 142.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$38
$12.26 (47.63%)
$37
17 days ago
(07-Aug-2025)
9/17 (52.94%)
$13.6 (55.74%)
238
Hold
$24
$-1.74 (-6.76%)
$23
17 days ago
(07-Aug-2025)
9/13 (69.23%)
$-0.4 (-1.64%)
171
Sell
$17
$-8.74 (-33.95%)
$12
17 days ago
(07-Aug-2025)
4/7 (57.14%)
$-7.4 (-30.33%)
186
Buy
$34
$8.26 (32.09%)
$30
1 months ago
(24-Jul-2025)
6/10 (60%)
$10.95 (47.51%)
106
Buy
$32
$6.26 (24.32%)
$32
1 months 29 days ago
(26-Jun-2025)
7/23 (30.43%)
$9.79 (44.08%)
118
Which stock is Yatin Suneja is most bullish on?
Which stock is Yatin Suneja is most reserved on?
What Year was the first public recommendation made by Yatin Suneja?
